SGC2085 hydrochloride is primarily utilized in research settings as a potent and selective inhibitor of the protein kinase CK2. This compound is instrumental in studying the role of CK2 in various cellular processes, including cell proliferation, apoptosis, and signal transduction. Researchers employ it to explore potential therapeutic applications in diseases where CK2 is implicated, such as cancer, inflammatory disorders, and neurodegenerative conditions. Its ability to modulate CK2 activity makes it a valuable tool for understanding the enzyme's function and for developing targeted therapies. Additionally, SGC2085 hydrochloride is used in biochemical assays to investigate the molecular mechanisms underlying CK2-related pathways, aiding in the discovery of novel drug candidates.